120 deltagare i AVAnT1A
I AVAnT1A finns det nu 120 deltagare totalt på alla forskningscentrum i Europa varav 35 går på vår mottagning i Malmö.Målet för studien är 2252 deltagare.
https://www.gppad.lu.se/artikel/120-deltagare-i-avant1a - 2025-11-13
Filetype
I AVAnT1A finns det nu 120 deltagare totalt på alla forskningscentrum i Europa varav 35 går på vår mottagning i Malmö.Målet för studien är 2252 deltagare.
https://www.gppad.lu.se/artikel/120-deltagare-i-avant1a - 2025-11-13
I det senaste numret av den populärvetenskapliga tidningen Vetenskap & Hälsa finns en artikel om AVAnT1A studien. Länk till AVAnT1A artikeln (öppnas i nytt fönster).Länk till alla artiklar i tidningen (öppnas i nytt fönster).
https://www.gppad.lu.se/artikel/vetenskap-halsa - 2025-11-13
Nu har vår mottagning i Kristianstad stängt och deltagare som tidigare kommit på besök i Kristianstad är välkomna till Malmö.All provtagning för ASTR1D efter födseln sker numera i Malmö. Vi har drop-in för ASTR1D provtagning på tisdagar kl 10:00-12:00. Vi finns på CRC, adress Jan Waldenströmsgata 35, i ett hus på sjukhusområdet bredvid KK.Länk till karta (nytt fönster)
https://www.gppad.lu.se/artikel/drop - 2025-11-13
Den 14 november är det Världsdiabetesdagen. Det är en dag då diabetes uppmärksammas över hela världen. Detta år är temat för dagen i Skåne, Hälsa och Välbefinnande vid Diabetes.I Malmö anordnas en eftermiddag med föreläsningar och utställningar om forskning och annat relaterat till diabetes torsdagen den 13 november. Alla är varmt välkomna!Programmet hittar ni här (nytt fönster)
https://www.gppad.lu.se/artikel/varldsdiabetesdagen-2025 - 2025-11-13
Vi har två nya sjuksköterskor på vår mottagning, Betty och Filippa. Betty jobbar i studierna IDAC, PreCise och GRaIn och Filippa jobbar i GRaIn och PreCise follow-up. Båda två har erfarenhet av att jobba med barn i olika åldrar och ser fram emot att träffa er.
https://www.gppad.lu.se/node/398 - 2025-11-13
Alla familjer som varit med i POInT borde få brev denna veckan. I brevet står det om barnet fått oralt insulin eller placebo i studien. Idag den 12 november har studiens resultat publicerats i den vetenskapliga tidningen Lancet, här är en länk till artikeln i PDF format (nytt fönster). Ett pressmeddelande har publicerats av Lunds universitet, det hittar ni här (nytt fönster).
https://www.gppad.lu.se/artikel/kolla-brevladan - 2025-11-13
Artikel om Gabriel som medverkar i den glutenfria gruppen i PreCiSe-studien. Klicka här för att komma till artikeln på diabetesportalen.se
Knut and Alice Wallenberg Foundation has in cooperation with Åsa Petersén produced a short film about Huntington's disease and Petersén's research on HD. Petersén was awarded Wallenberg Clinical Scholar in 2020. Link to the movie "Huntington's disease - the hunt for treatment" on YouTube
https://www.huntington-research.lu.se/article/film-about-hd-asa-petersen - 2025-11-13
Curious about HD research and wish to learn more? The European Huntington Association/Moving Forward Team is inviting you to a webinar in Norwegian on 22 November. Astri Arnesen, the President of the European Huntington Association, will speak about international HD research, Lasse Pihlstrøm, a Norwegian HD neurologist and researcher, will address HD studies and trials in Norway, and Åsa Petersén,
https://www.huntington-research.lu.se/article/hd-webinar-22-november-2023 - 2025-11-13
The European Huntington Association/Moving Forward Team’s webinar in now available on our site! You find it under Talks & Movies:Talks & Movies
https://www.huntington-research.lu.se/article/watch-webinar - 2025-11-13
The National meeting for HD is a yearly event arranged by the patients’ organization RHS. This year, 2023, it took place in Gothenburg on 30 November. All talks at the meeting are available on RHS website; only in Swedish.You find Åsa Petersén’s research update about 13 minutes into the film. To access the video, go to RHS website:RHS website
https://www.huntington-research.lu.se/article/petersen-gives-research-update-national-meeting-hd-sweden - 2025-11-13
Every spring, Huntington Disease Center in Lund traditionally hosts an information night on Huntington disease. This year is no exception! The program is set for the evening:Staff from the clinical team and representatives from the patients’ organization, RHS, as well as HD researchers, will give talks about different aspects of the the disease and the current research. And, as always, there will
https://www.huntington-research.lu.se/article/welcome-info-night-hd-22-april-2024 - 2025-11-13
Sofia Bergh, PhD student in TNU, gave two presentations on Huntington disease on 11 and 12 March 2024 during the NMT Days.This is an annual event, arranged by the Faculty of Science, the Faculty of Medicine and the Faculty of Engineering at Lund University. A week of talks and demonstrations on a variety of topics show today’s research, and students in upper secondary school and their teachers are
https://www.huntington-research.lu.se/article/bergh-presented-nmt-days - 2025-11-13
Åsa Petersén gave a talk about Huntington disease and her research for the patients' organization, RHS, in Stockholm on 12 March 2024, where she was invited.
https://www.huntington-research.lu.se/article/petersen-gave-hd-talk-stockholm - 2025-11-13
Sofia Bergh's talk from the NMT days is now available online. See more on the Talks & Movies page.
https://www.huntington-research.lu.se/article/see-sofia-berghs-talk-hd - 2025-11-13
Sofia passed her half time review on 28 May 2024. Sofia Bergh presented her work titled "Cellular and molecular mechanisms of hypothalamic pathology in Huntington disease and the amyotrophic lateral sclerosis/frontotemporal dementia disease spectrum" before the audience and the reviewers Niels Henning Skotte, research group leader, Department for Drug Design and Pharmacology, Molecular Neuroprotec
https://www.huntington-research.lu.se/article/congratulations-sofia-bergh - 2025-11-13
For the second time, the European Huntington Association/Moving Forward initiative for the Nordic countries will be hosting a webinar on research updates. The Webinar will be held on 11th June, from 18:00 CET to 19:15 CET. You need to register beforehand to be able to join.Registration link: https://us02web.zoom.us/meeting/register/tZEkdeyupz4oH9KRCnkguo_KMuS0Y6…Åsa Petersén will be talking about
https://www.huntington-research.lu.se/article/webinar-research-updates-nordic-countries - 2025-11-13
Oskar Simonsson har completed his Master's studies and passed with Distinction. Oskar has been with TNU since the end of October 2023 to work on his Master's thesis. In the end of May he presented his work "Effects of TDP-43 overexpression in oxytocin neurons on neuropathology and metabolism in mice". Congratulations to your Master of Science in Biomedicine, Oskar!
https://www.huntington-research.lu.se/article/congratulations-oskar - 2025-11-13
We are honoured to announce that Åsa Petersén has received a two-year grant from Hjärnfonden, The Swedish Brain Foundation, for the project The importance of variations in the CAG repeat for Huntington disease.The awarded amount for the two years is SEK 1 600 000.
https://www.huntington-research.lu.se/article/new-grant-hjarnfonden - 2025-11-13
Together with researchers from Germany, Canada, Turkey and the Czech Republic Åsa Petersén was awarded the JPND grant for the project Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease. In Sweden the grant is funded by Vetenskapsrådet, the Swedish Research Council, and Petersén was awarded SEK 2 500 000.To initiate the project, a kickoff meeting was held in Istanbu
https://www.huntington-research.lu.se/article/jpnd-project-kickoff-istanbul - 2025-11-13